SALEM CAPITAL MANAGEMENT INC - Q3 2016 holdings

$182 Million is the total value of SALEM CAPITAL MANAGEMENT INC's 64 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 18.8% .

 Value Shares↓ Weighting
JNJ SellJohnson & Johnson$8,383,000
-5.1%
70,965
-2.5%
4.60%
-9.7%
MSFT SellMicrosoft$8,003,000
+11.7%
138,934
-0.8%
4.39%
+6.2%
HON SellHoneywell Int'l$7,757,000
-0.6%
66,533
-0.8%
4.25%
-5.4%
UL SellUnilever PLC ADR$7,243,000
-3.4%
152,816
-2.4%
3.97%
-8.1%
GE SellGeneral Electric$6,817,000
-6.5%
230,145
-0.6%
3.74%
-11.0%
CVS SellCVS Health Corporation$6,784,000
-7.3%
76,230
-0.3%
3.72%
-11.8%
IP SellInternational Paper$6,708,000
+12.3%
139,805
-0.8%
3.68%
+6.8%
PG SellProcter & Gamble$5,832,000
+3.9%
64,982
-1.9%
3.20%
-1.1%
PCAR SellPaccar Inc.$5,180,000
+11.7%
88,123
-1.5%
2.84%
+6.2%
SLB SellSchlumberger, Ltd.$3,688,000
-1.4%
46,899
-0.8%
2.02%
-6.2%
NSRGY SellNestle S A ADR$3,577,000
+1.4%
45,262
-0.8%
1.96%
-3.6%
HAL SellHalliburton Co.$3,193,000
-1.8%
71,150
-0.9%
1.75%
-6.6%
MRO SellMarathon Oil Corp.$2,756,000
+4.6%
174,304
-0.7%
1.51%
-0.5%
DD SellDuPont$2,644,000
-13.6%
39,480
-16.4%
1.45%
-17.8%
COST SellCostco Wholesale Corp.$1,700,000
-5.0%
11,145
-2.2%
0.93%
-9.6%
MMM Sell3M Company$1,498,000
-6.0%
8,500
-6.6%
0.82%
-10.7%
ABT SellAbbott Laboratories$1,402,000
+5.6%
33,149
-1.8%
0.77%
+0.4%
XOM SellExxon Mobil$1,334,000
-7.5%
15,285
-0.6%
0.73%
-12.0%
NVS SellNovartis AG ADR$1,186,000
-44.7%
15,020
-42.2%
0.65%
-47.4%
HD SellHome Depot Inc.$1,120,000
-0.4%
8,700
-1.1%
0.61%
-5.2%
KMB SellKimberly-Clark$1,041,000
-15.4%
8,250
-7.8%
0.57%
-19.5%
T SellAT & T Corp.$1,014,000
-9.6%
24,970
-3.9%
0.56%
-14.1%
DOV SellDover Corp$792,000
+1.3%
10,750
-4.7%
0.43%
-3.8%
NFG SellNational Fuel Gas$684,000
-10.2%
12,650
-5.6%
0.38%
-14.6%
IBM SellInt'l Bus Machines$656,000
-11.4%
4,132
-15.2%
0.36%
-15.7%
GIS SellGeneral Mills$485,000
-27.6%
7,600
-19.1%
0.27%
-31.1%
SO SellSouthern Co.$408,000
-13.0%
7,950
-9.1%
0.22%
-17.0%
NXRA ExitNextera Enterprises Inc.$0-30,000
-100.0%
0.00%
CAT ExitCaterpillar$0-2,700
-100.0%
-0.12%
ESRX ExitExpress Scripts$0-2,845
-100.0%
-0.12%
BMY ExitBristol Myers Squibb$0-3,100
-100.0%
-0.13%
CTAS ExitCintas Corp$0-2,500
-100.0%
-0.14%
STR ExitQuestar Corp.$0-10,750
-100.0%
-0.16%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-10-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft38Q3 20228.6%
Honeywell Int'l38Q3 20225.5%
Merck & Co.38Q3 20225.6%
Weyerhaeuser Co.38Q3 20224.8%
Cisco Systems38Q3 20225.3%
Johnson & Johnson38Q3 20225.1%
Pfizer Inc.38Q3 20225.3%
International Paper38Q3 20224.6%
CVS Health Corporation38Q3 20225.6%
Verizon Communications38Q3 20223.1%

View SALEM CAPITAL MANAGEMENT INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-29
13F-HR2022-07-27
13F-HR2022-04-07
13F-HR2022-01-18
13F-HR2021-10-12
13F-HR2021-07-13
13F-HR2021-04-15
13F-HR2021-01-12
13F-HR2020-10-13
13F-HR2020-07-20

View SALEM CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (182372000.0 != 182376000.0)

Export SALEM CAPITAL MANAGEMENT INC's holdings